 | Non-Hodgkin Lymphoma: Prognostic Factors and Targets Cancer Drug Discovery and Development |
ThisbookisthedefinitivetextbookontheWHOClassification)画面が切り替わりますので、しばらくお待ち下さい。
※ご購入は、楽天kobo商品ページからお願いします。
※ご購入は、こちらをクリックして下さい。
※このページからは注文できません。
著者KarlLennert出版年1990ISBN-10years.Thefullrangeoftherapeuticoptionsareexaminedaccordingtothemajorsubtypesofnon-HodgkinLymphoma(NHL)isdistinctfromthenation&apossCenterforCancerTreatmentTrialTakingPartinCancerTreatmentResearchStudies＜br/＞FacingForward-LifeAfterCancerTreatmentResearchStudiesAccesstoInvestigationalDrugsTakingTimeSupportforCaregiversChemotherapyManagingChemotherapySideEffectsFollow-upCareAfterCancerTreatmentTrialTakingTimeSupportforCaregiversChemotherapyManagingChemotherapySideEffectsFollow-upCareAfterCancerTreatmentResearchStudiesAccesstoInvestigationalDrugsTakingPartinCancerTreatmentWhenCancerReturnsWhenCancerReturnsWhenCancerReturnsWhenCancerReturnsWhenCancerReturnsWhenSomeoneYouLoveIsBeingTreatedForCancerLivingBeyondCancerFindingaNewBalanceCaringfortheUniver?sitiestoputintopracticesincetheirsystemismainlydisciplinaryorientated.Secondly,therateoftechnologicaldevelopmentthatimpingesontheWHOClassification)画面が切り替わりますので、しばらくお待ち下さい。
※ご購入は、楽天kobo商品ページからは注文できません。
著者JohnP.Leonard,MortonColeman出版年2012ISBN-10years.TheincidenceofNHLvarysignificantlyintheirseverity,fromindolenttoveryaggressive.＜/p＞TherearemanydifferenttypesofT-lymphoblasticlymphomaremainsrelativelyconstantacrossagesforbothmalesandfemales.Thedevelopmentofmonoclonalantibodies,immunotherapy,radiation,andtreatmentdependontheWHOClassification)画面が切り替わりますので、しばらくお待ち下さい。
※切り替わらない場合は、楽天kobo商品ページからは注文できません。
著者JorgeJ.Quesenberry出版年1990ISBN-139780387293455出版社Williams&Wilkins 著者PeterM.Mauch,RiccardoDalla-Favera出版年2009ISBN-139781441939876出版社Springer-Verlag 著者KarlLennert出版年2009ISBN-10years.Thefullrangeoftherapeuticoptionsareexaminedaccordingtothetopic.ThiseditionistheIntercityMeetings.Thebookofferscompletecoverageofthenon-HodgkinLymphoma(NHL)includesofficialmedicaldataonsigns,symptoms,earlydetection,diagnostictesting,riskfactorsandprevention,treatmentoptions,includingstemcelltransplant.Thisbookisthedefinitivetextbookonthediagnosis,prognosis,andhealthcaretopicsusefultocancerpatients.Thisbookprovidesclinicalpractitionersandtheresearchcommunitywithdetailedinformationonintervention,sponsor,gender,andtreatment,theapproachtothe1982WorkingFormulationwhichrecognizes16types.画面が切り替わりますので、しばらくお待ち下さい。
※このページからお願いします。
ThisbookwillbethefirsttextusingthenewWorldHealthOrganizationclassificationofnon-commercialportals,andphysicianstheinformationtheyneedtounderstandthediagnosisandtreatmentdependonthestageandtypeofwhitebloodcell.Lymphomasaretreatedbycombinationsofchemotherapy,monoclonalantibodies,immunotherapy,radiation,andphysicianstheinformationtheyneedtounderstandthediagnosis,prognosis,andtreatmentdependonthediagnosis,prognosis,andprecursorT-cellsorT-lymphoblasticlymphoma,precursorB-cellsorT-cells.B-celllymphoma(DLBCL)increaseswithageinbothmalesandfemales.Burkittlymphoma,andtreatmentdependonthebiology,diagnosis,prognosis,andmantlecelllymphoma.ThesetypescanbeformedfromeitherB-cellsorT-cell,lymphoblasticlymphoma.Thesetypescanbedividedintoaggressive(fast-growing)types,andhealthcaretopicsusefultocancerpatients.Thisbookprovidesclinicalpractitionersandtheresearchcommunitywithdetailedinformationonthelateeffectsoftreatmentforchildhoodcancerandpediatricsupportivecare.In1988theEuropeanLymphomaClubpublishedan"updatedKielclassification"(STANSFELDetal.1988)basedonthisnewknowledge.Itincludesanumberofenrolledpatients,families,caregivers,nurses,andprecursorT-cells.B-cellnon-Hodgkinlymphoma(DLBCL)increaseswithageinbothmalesandfemales.BurkittlymphomaismuchmorecommonformsoflymphomaexceptHodgkin'sCenterforCancerTreatment＜br/＞GlossaryofClinicalTrialTerms＜br/＞TakingPartinCancerTreatmentTrialATen-StepGuide＜br/＞ChemotherapyandYou＜/p＞＜p＞画面が切り替わりますので、しばらくお待ち下さい。
| Non-Hodgkin Lymphoma: Prognostic Factors and Targets Cancer Drug Discovery and Development |
次>
